Can an Epilepsy Drug Be the Answer to Preventing Alzheimer’s Dementia?

Doctor shows the patient how to use daily dose pills

An exciting research study has concluded at Johns Hopkins University and the results could be great news for the millions of patients who suffer from Alzheimer’s dementia. Epilepsy is a common neurological disorder that affects more than 50 million people in the world. A new drug, antiepileptic levetiracetam, has proved to be successful in reducing […]

Continue reading


Feasibility of Predicting MCI/AD Using Neuropsychological Tests and Serum β-Amyloid.

We examined the usefulness of brief neuropsychological tests and serum Aβ as a predictive test for detecting MCI/AD in older adults. Serum Aβ levels were measured from 208 subjects who were cognitively normal at enrollment and blood draw. Twenty-eight of the subjects subsequently developed MCI (n = 18) or AD (n = 10) over the […]

Continue reading